Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
Novartis
Novartis
M.D. Anderson Cancer Center
Stanford University
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center